# AT&T Inc.: financial statements, quarterly

T · NYSE · CIK 732717 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/t.md) · [Financials](/companies/t/financials.md) · [Filings](/companies/t/filings.md) · [Insiders](/companies/t/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/t/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [32.0](/filings/0000732717-24-000009.md) | [30.0](/filings/0000732717-25-000023.md) | [29.8](/filings/0000732717-25-000080.md) | [30.2](/filings/0000732717-25-000171.md) | [32.3 d](/filings/0000732717-26-000120.md) | [30.6](/filings/0000732717-26-000206.md) | [30.8](/filings/0000732717-26-000297.md) | [30.7](/filings/0000732717-26-000372.md) | [33.5 d](/filings/0000732717-26-000120.md) | [31.5](/filings/0000732717-26-000206.md) | [31.6](/filings/0000732717-26-000297.md) | [32.3](/filings/0000732717-26-000372.md) |
| Cost of revenue | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $bn | [7.5 d](/filings/0000732717-26-000120.md) | [7.0](/filings/0000732717-25-000023.md) | [7.0](/filings/0000732717-25-000080.md) | [7.0](/filings/0000732717-25-000171.md) | [7.4 d](/filings/0000732717-26-000120.md) | [7.1](/filings/0000732717-26-000206.md) | [6.9](/filings/0000732717-26-000297.md) | [7.5](/filings/0000732717-26-000372.md) | [7.4 d](/filings/0000732717-26-000120.md) | [7.3](/filings/0000732717-26-000206.md) | [7.2](/filings/0000732717-26-000297.md) | [7.4](/filings/0000732717-26-000372.md) |
| Operating income | $bn | [5.3](/filings/0000732717-24-000009.md) | [5.8](/filings/0000732717-25-000023.md) | [5.8](/filings/0000732717-25-000080.md) | [2.1](/filings/0000732717-25-000171.md) | [5.3 d](/filings/0000732717-26-000120.md) | [5.8](/filings/0000732717-26-000206.md) | [6.5](/filings/0000732717-26-000297.md) | [6.1](/filings/0000732717-26-000372.md) | [5.8 d](/filings/0000732717-26-000120.md) | [6.7](/filings/0000732717-26-000206.md) | [7.0](/filings/0000732717-26-000297.md) | [4.1](/filings/0000732717-26-000372.md) |
| Interest expense | $bn | [1.7 d](/filings/0000732717-24-000009.md) | [1.7](/filings/0000732717-24-000022.md) | [1.7](/filings/0000732717-24-000053.md) | [1.7](/filings/0000732717-25-000171.md) | [1.7 d](/filings/0000732717-26-000120.md) | [1.7](/filings/0000732717-26-000206.md) | [1.7](/filings/0000732717-26-000297.md) | [1.7](/filings/0000732717-26-000372.md) | [1.8 d](/filings/0000732717-26-000120.md) | [1.8](/filings/0000732717-26-000206.md) | [1.9](/filings/0000732717-26-000297.md) | [2.0](/filings/0000732717-26-000372.md) |
| Income tax | $bn | [0.4 d](/filings/0000732717-26-000120.md) | [1.1](/filings/0000732717-25-000023.md) | [1.1](/filings/0000732717-25-000080.md) | [1.3](/filings/0000732717-25-000171.md) | [0.9 d](/filings/0000732717-26-000120.md) | [1.3](/filings/0000732717-26-000206.md) | [1.2](/filings/0000732717-26-000297.md) | [1.0](/filings/0000732717-26-000372.md) | [0.1 d](/filings/0000732717-26-000120.md) | [1.2](/filings/0000732717-26-000206.md) | [0.8](/filings/0000732717-26-000297.md) | [1.4](/filings/0000732717-26-000372.md) |
| Net income | $bn | [2.2 d](/filings/0000732717-26-000120.md) | [3.4](/filings/0000732717-25-000023.md) | [3.6](/filings/0000732717-25-000080.md) | [(0.2)](/filings/0000732717-25-000171.md) | [4.1 d](/filings/0000732717-26-000120.md) | [4.4](/filings/0000732717-26-000206.md) | [4.5](/filings/0000732717-26-000297.md) | [9.3](/filings/0000732717-26-000372.md) | [3.8 d](/filings/0000732717-26-000120.md) | [3.8](/filings/0000732717-26-000206.md) | [4.6](/filings/0000732717-26-000297.md) | [0.9](/filings/0000732717-26-000372.md) |
| Diluted EPS | $ per share | not reported | [0.47](/filings/0000732717-25-000023.md) | [0.49](/filings/0000732717-25-000080.md) | [(0.03)](/filings/0000732717-25-000171.md) | not reported | [0.61](/filings/0000732717-26-000206.md) | [0.62](/filings/0000732717-26-000297.md) | [1.29](/filings/0000732717-26-000372.md) | not reported | [0.54](/filings/0000732717-26-000206.md) | [0.66](/filings/0000732717-26-000297.md) | [0.12](/filings/0000732717-26-000372.md) |
| Basic EPS | $ per share | not reported | [0.47](/filings/0000732717-25-000023.md) | [0.49](/filings/0000732717-25-000080.md) | [(0.03)](/filings/0000732717-25-000171.md) | not reported | [0.61](/filings/0000732717-26-000206.md) | [0.62](/filings/0000732717-26-000297.md) | [1.29](/filings/0000732717-26-000372.md) | not reported | [0.54](/filings/0000732717-26-000206.md) | [0.66](/filings/0000732717-26-000297.md) | [0.12](/filings/0000732717-26-000372.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [6.7](/filings/0000732717-26-000120.md) | [3.5](/filings/0000732717-25-000023.md) | [3.1](/filings/0000732717-25-000080.md) | [2.6](/filings/0000732717-25-000171.md) | [3.3](/filings/0000732717-26-000372.md) | [6.9](/filings/0000732717-26-000206.md) | [10.5](/filings/0000732717-26-000297.md) | [20.3](/filings/0000732717-26-000372.md) | [18.2](/filings/0000732717-26-000372.md) | [12.0](/filings/0000732717-26-000206.md) | [17.6](/filings/0000732717-26-000297.md) | [10.8](/filings/0000732717-26-000372.md) |
| Current assets | $bn | [36.5](/filings/0000732717-25-000013.md) | [30.4](/filings/0000732717-24-000022.md) | [29.9](/filings/0000732717-24-000053.md) | [29.8](/filings/0000732717-24-000059.md) | [31.2](/filings/0000732717-26-000120.md) | [33.8](/filings/0000732717-25-000023.md) | [39.3](/filings/0000732717-25-000080.md) | [54.6](/filings/0000732717-25-000171.md) | [48.7](/filings/0000732717-26-000372.md) | [46.3](/filings/0000732717-26-000206.md) | [51.8](/filings/0000732717-26-000297.md) | [52.3](/filings/0000732717-26-000372.md) |
| Total assets | $bn | [407](/filings/0000732717-25-000013.md) | [399](/filings/0000732717-24-000022.md) | [398](/filings/0000732717-24-000053.md) | [394](/filings/0000732717-24-000059.md) | [395](/filings/0000732717-26-000120.md) | [397](/filings/0000732717-25-000023.md) | [405](/filings/0000732717-25-000080.md) | [423](/filings/0000732717-25-000171.md) | [420](/filings/0000732717-26-000372.md) | [421](/filings/0000732717-26-000206.md) | [428](/filings/0000732717-26-000297.md) | [446](/filings/0000732717-26-000372.md) |
| Current liabilities | $bn | [51.1](/filings/0000732717-25-000013.md) | [44.8](/filings/0000732717-24-000022.md) | [42.4](/filings/0000732717-24-000053.md) | [40.7](/filings/0000732717-24-000059.md) | [46.9](/filings/0000732717-26-000120.md) | [48.0](/filings/0000732717-25-000023.md) | [48.6](/filings/0000732717-25-000080.md) | [53.9](/filings/0000732717-25-000171.md) | [53.8](/filings/0000732717-26-000372.md) | [50.4](/filings/0000732717-26-000206.md) | [53.4](/filings/0000732717-26-000297.md) | [60.3](/filings/0000732717-26-000372.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $bn | [133](/filings/0000732717-25-000013.md) | not reported | not reported | not reported | [122](/filings/0000732717-26-000120.md) | not reported | not reported | not reported | [135](/filings/0000732717-26-000120.md) | not reported | not reported | not reported |
| Current portion of debt | $bn | [9.5](/filings/0000732717-25-000013.md) | [7.1](/filings/0000732717-24-000022.md) | [5.2](/filings/0000732717-24-000053.md) | [2.6](/filings/0000732717-24-000059.md) | [5.1](/filings/0000732717-26-000120.md) | [8.9](/filings/0000732717-25-000023.md) | [9.3](/filings/0000732717-25-000080.md) | [11.4](/filings/0000732717-25-000171.md) | [9.0](/filings/0000732717-26-000372.md) | [6.8](/filings/0000732717-26-000206.md) | [9.3](/filings/0000732717-26-000297.md) | [9.5](/filings/0000732717-26-000372.md) |
| Short-term borrowings | $bn | [2.1](/filings/0000732717-25-000013.md) | not reported | not reported | not reported | [0.0](/filings/0000732717-26-000120.md) | not reported | not reported | not reported | [0.0](/filings/0000732717-26-000120.md) | not reported | not reported | not reported |
| Shareholders' equity | $bn | [117](/filings/0000732717-26-000120.md) | [119](/filings/0000732717-25-000080.md) | [119](/filings/0000732717-25-000171.md) | [116](/filings/0000732717-25-000171.md) | [118](/filings/0000732717-26-000372.md) | [120](/filings/0000732717-26-000297.md) | [121](/filings/0000732717-26-000372.md) | [127](/filings/0000732717-26-000372.md) | [126](/filings/0000732717-26-000372.md) | [126](/filings/0000732717-26-000297.md) | [126](/filings/0000732717-26-000372.md) | [123](/filings/0000732717-26-000372.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [11.4 d](/filings/0000732717-26-000120.md) | [7.5](/filings/0000732717-25-000023.md) | [9.1 d](/filings/0000732717-25-000080.md) | [10.2 d](/filings/0000732717-25-000171.md) | [11.9 d](/filings/0000732717-26-000120.md) | [9.0](/filings/0000732717-25-000023.md) | [9.8 d](/filings/0000732717-25-000080.md) | [10.2 d](/filings/0000732717-25-000171.md) | [11.3 d](/filings/0000732717-26-000120.md) | [7.6](/filings/0000732717-26-000206.md) | [10.8 d](/filings/0000732717-26-000297.md) | [10.5 d](/filings/0000732717-26-000372.md) |
| Capital expenditure | $bn | [4.6 d](/filings/0000732717-26-000120.md) | [3.8](/filings/0000732717-25-000023.md) | [4.4 d](/filings/0000732717-25-000080.md) | [5.3 d](/filings/0000732717-25-000171.md) | [6.8 d](/filings/0000732717-26-000120.md) | [4.3](/filings/0000732717-26-000206.md) | [4.9 d](/filings/0000732717-26-000297.md) | [4.9 d](/filings/0000732717-26-000372.md) | [6.8 d](/filings/0000732717-26-000120.md) | [4.9](/filings/0000732717-26-000206.md) | [5.7 d](/filings/0000732717-26-000297.md) | [5.1 d](/filings/0000732717-26-000372.md) |
| Dividends paid | $bn | [2.0 d](/filings/0000732717-26-000120.md) | [2.0](/filings/0000732717-25-000023.md) | [2.1 d](/filings/0000732717-25-000080.md) | [2.0 d](/filings/0000732717-25-000171.md) | [2.0 d](/filings/0000732717-26-000120.md) | [2.1](/filings/0000732717-26-000206.md) | [2.0 d](/filings/0000732717-26-000297.md) | [2.0 d](/filings/0000732717-26-000372.md) | [2.0 d](/filings/0000732717-26-000120.md) | [2.0](/filings/0000732717-26-000206.md) | [2.0 d](/filings/0000732717-26-000297.md) | [2.0 d](/filings/0000732717-26-000372.md) |
| Share repurchases | $bn | [0.0 d](/filings/0000732717-26-000120.md) | [0.2](/filings/0000732717-25-000023.md) | [0.0 d](/filings/0000732717-25-000080.md) | [0.0 d](/filings/0000732717-25-000171.md) | [0.0 d](/filings/0000732717-26-000120.md) | [0.2](/filings/0000732717-26-000206.md) | [1.0 d](/filings/0000732717-26-000297.md) | [1.5 d](/filings/0000732717-26-000372.md) | [1.8 d](/filings/0000732717-26-000120.md) | [2.5](/filings/0000732717-26-000206.md) | [2.2 d](/filings/0000732717-26-000297.md) | [2.8 d](/filings/0000732717-26-000372.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities, us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [7,474](/filings/0000732717-24-000022.md) | [7,180](/filings/0000732717-24-000053.md) | [7,185](/filings/0000732717-24-000059.md) | [7,193](/filings/0000732717-25-000023.md) | [7,198](/filings/0000732717-25-000080.md) | [7,208](/filings/0000732717-25-000171.md) | [7,223](/filings/0000732717-26-000206.md) | [7,219](/filings/0000732717-26-000297.md) | [7,169](/filings/0000732717-26-000372.md) | [7,027](/filings/0000732717-26-000206.md) | [6,946](/filings/0000732717-26-000297.md) | [6,844](/filings/0000732717-26-000372.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,736,473,433 at 2026-10-15, from the cover of the [10-Q filed 2026-10-21](/filings/0000732717-26-000372.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.